Abstract
E-cigarette use rates are increasing among youth and adults, despite limited knowledge about the safety, risks, and potential for this product in substituting for or reducing other tobacco use. Understanding how to characterize and assess e-cigarette dependence will be important for evaluating the public health impact of e-cigarettes and considering prevention and intervention strategies. To provide an initial review of constructs to consider when assessing e-cigarette dependence, a content expert group within the Tobacco Center for Regulatory Science (TCORS) Measurement Workgroup engaged in a review of published manuscripts and 12 tobacco dependence measures, followed by review of suggested dependence domains by a 10-person external subject-matter expert panel. The final domains selected to be considered in the development of a measure of e-cigarette dependence included: 1) Quantity and frequency of use, 2) Tolerance, 3) Perceived benefits, 4) Withdrawal symptoms, 5) Craving/urge to use, 6) Use despite harm, 7) Impaired control, 8) Automaticity, 9) Preferred over competing rewards, and 10) Sensory dependence. Similarities and differences in potential features of e-cigarette dependence compared with dependence on other tobacco products is discussed. Future work will evaluate these dependence items and constructs in a sample of e-cigarette users with a goal of developing a valid, brief, standardized measure of e-cigarette dependence.
Keywords: e-cigarette, dependence, electronic cigarette, tobacco
1 Introduction
Electronic cigarettes (e-cigarettes) are battery-operated devices used to vaporize solutions that may contain nicotine and flavors1. E-cigarette devices vary widely; they may be disposable or rechargeable; include manual buttons to change heating, voltage, and wattage; and contain e-liquids which vary in their specific constituents, nicotine concentrations, and flavors. E-cigarette use rates have increased significantly across the globe2,3, despite limited evidence regarding the health effects or the potential for this product to replace or reduce other tobacco use. To address these gaps in knowledge, the Food and Drug Administration Center for Tobacco Products has outlined research on addiction as a priority area, including studies of how tobacco product characteristics (such as flavors or product design) impact dependence. To further these research objectives, reliable and valid means of assessing dependence to e-cigarettes and other new tobacco products are needed.
1.1 Conceptualizing Dependence Among E-Cigarette Users
Given that nicotine itself is a primary reinforcer that can lead to dependence when used repeatedly4–6, it is likely that some aspects of dependence will overlap between e-cigarettes containing nicotine and other tobacco products. However, characteristics of e-cigarette products could contribute to dependence in unique ways. For example, characteristics of the product that are consistently paired with nicotine can acquire reinforcing properties through associative learning7, and the cues associated with e-cigarette use are unique compared to traditional cigarettes (e.g., e-liquid flavors, vape clouds, contexts where e-cigarettes are used, and device type including the ability to customize features). Thus, the goal of the current paper is to review features of e-cigarettes to consider in assessing e-cigarette dependence and to provide guidance on dependence constructs that could be considered when developing such a measure.
1.2 The Present Study
The Tobacco Center for Regulatory Science (TCORS) Measurement Workgroup was convened to consider aspects to include in a measure of e-cigarette dependence. To date, only one e-cigarette dependence measure has been developed; the Penn State Electronic Cigarette Dependence Index assesses frequency, craving, and withdrawal8. The workgroup reviewed this index as well as several measures of tobacco dependence, with the goal of assembling multiple aspects of dependence, such as those related to the primary reinforcement process of nicotine exposure (e.g., withdrawal, tolerance, craving) as well as those related to cue-driven or habitual processes driven by associative learning (e.g., automaticity, perceived benefits of use, preference over competing rewards).
2 Methods
2.1 Subject Matter Expert Discussions
In June 2015, six subject matter experts (Grana, Fishbein, Foulds, Krishnan-Sarin, Roditis, Sussman) conducted a literature search in Google Scholar using the key words “nicotine dependence” and “reviews” and reviewed the first 200 pages to identify existing nicotine and tobacco dependence measures. The workgroup selected specific measures that would be applicable to the assessment of e-cigarette dependence (Table 1). These measures were used to identify potential dependence constructs that were sent to an external expert panel for review.
Table 1.
Tobacco Dependence Measures Reviewed
Measure | Description |
---|---|
Cigarette Dependence Scale (CDS)34 | 12 items, assesses a total dependence score (e.g., "For you, quitting smoking for good would be" rated from 1=very easy to 5=impossible) |
Dimensions of Tobacco Dependence Scale (DTDS)35 | 54 items, 4 factors, assesses tobacco dependence in adolescents: social reinforcement, emotional reinforcement, sensory reinforcement, physical reinforcement |
Fagerstrom Test for Nicotine Dependence36 | 6 items, intending to assess physical dependence, rated 0–2=very low dependence, 3–4=low dependence, 5=medium, 6–7=high dependence, 8–10=very high dependence |
Hooked on Nicotine Checklist (HONC)18,37 | 10 items, a proxy for the ICD-10 criteria of tobacco dependence, intended to assess the development of dependence in young people, assessing early symptoms of dependence and the loss of autonomy over tobacco use (e.g., "Do you smoke now because it is really hard to quit?") |
Minnesota Nicotine Withdrawal Scale38,39 | 8 items, assesses a single factor of nicotine dependence based on DSM-IV withdrawal criteria (i.e., craving, irritability, anxiety, difficulty concentrating, restlessness, increased appetite/weight gain, depressed or sad mood, insomnia) |
Nicotine Dependence Syndrome Scale (NDSS)40 | 19 items, assesses a total dependence score and 5 factors: smoking drive (i.e., strong urges), behavioral priority (i.e., smoking preferred over other competing reinforcers), tolerance, continuity (i.e., smoking with little interruption), and stereotypy (i.e., smoking at a constant rate uninfluenced by contextual stimuli) |
Patient-Reported Outcomes Measurement Information System (PROMIS)30,31 | 32 items, assesses a unidimensional set of nicotine dependence items for daily and non-daily smokers with items derived from validated existing measures and focus group testing (Edelen, Tucker, Shadel, Stucky, & Cai, 2012); 22 items are common across daily and non-daily smokers, with 5 unique to daily or nondaily smokers |
Penn State Electronic Cigarette Dependence Index8 | 10 items, questions can be modified to assess cigarette or e-cigarette dependence (e.g., "Is it hard to keep from using an electronic cigarette in places where you are not supposed to?") |
The Population Assessment of Tobacco and Health (PATH) Study41 | 20 items, assesses craving, tolerance, loss of control, withdrawal |
Tobacco Craving Questionnaire42 | 17 items, assesses 4 specific constructs: emotionality (i.e., anticipated relief from negative mood or withdrawal), expectancy (i.e., anticipated positive outcomes of smoking), compulsivity (i.e., inability to control tobacco use), purposefulness (i.e., intention and planning to smoke for positive outcomes) |
Tobacco Use Disorder (DSM-5, Appendix B)13 | 11 items, used as diagnostic criteria to assess severity of tobacco use disorder, at least 2 symptoms present in the last year indicates tobacco use disorder, rated 2–3 symptoms=mild, 4–5=moderate, 6+=severe |
Wisconsin Inventory of Smoking Dependence Motives (WISDM)19 | 68 items, assesses 13 factors: affiliative attachment, automaticity, behavioral choice/melioration, cognitive enhancement, loss of control, craving, cue exposure/associative processes, negative reinforcement, positive reinforcement, social/environmental goads, taste/sensory properties, tolerance, weight control |
2.2 External Expert Panel Review
Potential constructs with sample items (see Appendix A) were sent to 10 external subject matter experts who were told that the goal was to compile a comprehensive list of constructs to be considered in the creation of an e-cigarette dependence measure. Experts provided written feedback on whether the constructs and definitions were 1) understandable, 2) necessary for the creation of comprehensive dependence measures, and 3) appropriate in their specificity. Reviewers could also provide general feedback about the constructs and whether anything should be kept, deleted, modified, or merged with another construct. The list of constructs was further modified based on responses from 7 of the 10 reviewers; the other 3 reviewers verbally indicated that they did not have any changes. The final list of constructs and sample items identified are described in Table 2. Two constructs from the original list (“emotional reactions to encourage use” and “affiliative attachment”) were reclassified (“perceived benefits” and “preference over competing rewards”) as experts believed these terms more accurately described dependence processes. Additionally, one construct (“social goads”) was replaced (“use despite harm”) based on feedback that the latter was more diagnostic and central to dependence.
Table 2.
Potential E-Cigarette Dependence Constructs and Example Items
Construct | Example Items |
---|---|
Quantity and Frequency of Use |
|
Tolerance |
|
Perceived Benefits |
|
Withdrawal Symptoms |
|
Craving/Urges to Use |
|
Use Despite Harm |
|
Impaired Control |
|
Automaticity |
|
Preferred Over Competing Rewards |
|
Sensory Dependence |
|
Note: Items are presented as examples representing each dependence construct. Further psychometric testing of items, including item structure and scoring, are needed to develop a validated measure of e-cigarette dependence.
3 Results and Discussion: Final E-cigarette Dependence Constructs to Consider
3.1 Quantity and frequency of use
While patterns of e-cigarette use are likely important to the assessment of e-cigarette dependence, quantifying e-cigarette use behaviors is not easy, especially given the wide variability in terminology, device type (e.g., “e-cigarettes”, “e-hookahs”, “vape pens”1), nicotine concentrations, and puffing/vaping behaviors. Still it was the opinion of the subject matter experts that heaviness of use is an important measure to obtain, either as part of an e-cigarette dependence measure or separately alongside smoking history (please see guidance about measuring use provided by Weaver and colleagues, this volume).
3.2 Tolerance
Tolerance is a common feature of dependence, representing a markedly diminished effect of the product over time or needing increased amounts of the product to achieve the same effect6. However, e-cigarette tolerance may not necessarily be as straightforward as measuring changes in quantity or frequency of use. E-cigarette products are highly variable and many are customizable, including the ability to change device and e-liquid features such as the device shape, size, temperature, nicotine concentration, vapor flow, and flavor, which can impact the delivery of nicotine and other constituents. For example, larger capacity batteries that heat the e-liquid to higher temperatures produce more aerosol per puff and supply more nicotine and other constituents9. Therefore, evidence of tolerance could be reflected not only by the person using e-cigarettes more frequently, but by the person increasing nicotine concentration, changing device characteristics or e-liquid constituents to get the desired effect.
3.3 Perceived Benefits
As described earlier, e-cigarettes deliver nicotine and flavors and a variety of other constituents. Nicotine is not only a primary reinforcer, but it has properties that enhance the reinforcing effects of other rewarding stimuli7. Thus, the perceived benefits of e-cigarette use (e.g., helps you feel better, makes experiences more enjoyable) may be related both to the direct pharmacological effects of nicotine, similar to other tobacco products, and also to the unique product-related characteristics of e-cigarettes (e.g., flavored e-liquids) through associative learning processes.
3.4 Withdrawal Symptoms
Withdrawal symptoms (e.g., changes in affect, restlessness, difficulty concentrating) are experienced when a user stops using the addictive substance, which then promote continued use to alleviate these symptoms10. Pharmacological withdrawal from nicotine is likely similar across tobacco products. However, the degree of withdrawal from e-cigarettes may vary, given differences in nicotine delivery and more continuous use patterns (e.g., repeated bouts of puffing throughout the day). Current e-cigarette devices can yield peak levels of nicotine similar to cigarettes, but these levels may not be achieved as rapidly11. Prior studies have found that exclusive e-cigarette users experience nicotine withdrawal symptoms, albeit at lower rates than cigarette smokers8,12.
3.5 Craving/urges to use
Craving, or urge to use, is a key symptom experienced both during abstinence and while continuing to use the substance that motivates sustained use6,13. Craving is known to persist for a long time after abstinence is achieved and is an established predictor of lapse or relapse to use of a variety of addictive substances5. Craving for e-cigarettes likely has commonalities with craving for cigarettes, but may be linked to unique cues associated with e-cigarette use, such as vape shops, vape clouds, and e-cigarette paraphernalia.
3.6 Use Despite Harm
Continued use despite harm reflects persistent use despite negative physical, psychological, or social consequences6. E-cigarettes may be perceived as safer and more socially acceptable than conventional tobacco products, so fewer consequences may be endorsed. Although the long-term health effects of e-cigarette use are not yet known for these relatively new products, current evidence suggests the potential for negative cardiovascular and pulmonary effects of e-cigarettes14–16.
3.7 Impaired Control
Impaired control is defined as a breakdown of an intention to limit consumption6. Impaired control may be an early nicotine dependence symptom,17 reflecting a loss of autonomy over use related to neuropharmacological, psychological, or behavioral mechanisms18. For example, impaired control over e-cigarette use may be related to difficulty reducing or limiting use in terms of quantity, frequency, as well as nicotine level.
3.8 Automaticity
Automaticity describes a behavior that has an automatic or habitual response pattern that is usually acquired through learning and repetition, such as repeated tobacco use19,20. For example, individuals may find themselves reaching for their e-cigarette or vaping without thinking about it. Other behaviors related to e-cigarette use, such as dripping21,22 and vape tricks23,24, may also become automatic, habitual processes.
3.9 Preferred over competing rewards
This construct is the tendency to forgo other rewards or activities to use the substance and is an important aspect of dependence in behavioral economics models of addiction25,26. For example, an individual may prefer tobacco use over other activities or rewards or not engage in certain activities where use is not permitted, although e-cigarette use may not be restricted in public places in the same way as other tobacco products27.
3.10 Sensory Dependence
This construct relates to the positive consequences associated with specific taste and sensory stimuli when using the addictive substance19, which may motivate continued use or a return to use following abstinence. Compared to use of conventional tobacco products, e-cigarette use may be associated with unique sensory experiences related to characteristics of the device or e-liquid constituents (including over 7000 e-liquid flavors28) which can impact the subjective experience of e-cigarettes. E-cigarette users note many positive sensory aspects of e-cigarette use, including enjoying flavors, a “throat hit”, and the emission of thick vapor clouds that can be used for vape tricks23,24,29 which all may serve to reinforce e-cigarette use behavior.
4 Conclusions
The purpose of this manuscript is to provide guidance on domains or constructs to consider when developing a measure of e-cigarette dependence. Twelve existing measures of dependence were examined in detail and 10 dependence domains were established, plausibly applicable to e-cigarettes. Several constructs are likely common between cigarette and e-cigarette dependence, such as craving, withdrawal, and impaired control, suggesting that existing measures of nicotine dependence could be adapted to measure these constructs in e-cigarette users. One such measure is the Patient Reported Outcomes Measurement Information System (PROMIS) Nicotine Dependence Item Bank30–32. Of note, the 22-item version of the PROMIS incorporates most of the domains identified by the working group, with the exceptions of tolerance, perceived benefits, and sensory dependence. However, our review also suggests that several factors unique to e-cigarette products, such as the ability to modify the experience through device characteristics and the variety of e-liquids, should be considered when assessing e-cigarette dependence, and as a result, existing nicotine dependence measures may be inadequate templates for measuring some domains of e-cigarette dependence, such as sensory dependence. Interestingly, one prior study observed that although dependence scores were positively related to e-liquid nicotine concentration, the zero nicotine users also showed signs of dependence8. Thus, even without nicotine, e-cigarette users may develop a strong affiliative attachment to e-cigarettes, and it will be important to consider the unique sensory and behavioral cues for e-cigarette use when assessing e-cigarette dependence.
The next steps for the TCORS dependence workgroup will include examining the use and validity of the dependence constructs described above by evaluating responses among current e-cigarette users on items from existing nicotine dependence measures that have been adapted for e-cigarettes as well as expanded items reflecting unique aspects of e-cigarette use. Following recommendations for an ideal tobacco dependence assessment33, a primary goal will be to develop a measure assessing e-cigarette dependence with 1) clear, straightforward items and scoring such that the measure can be adapted to various e-cigarette devices and brief enough for possible use in clinical settings, 2) constructs and domains that are theoretically and empirically central to dependence that can be generalized to e-cigarette use, and with 3) sound psychometric properties (e.g., construct, convergent, and discriminant validity compared with biochemical and other standard assessment measures). Additionally, e-cigarette dependence assessment may differ between youth and adults, and this will be an important area for future research. Ultimately, identifying the optimal ways of characterizing and assessing e-cigarette dependence will be important for advancing our understanding of the public health impact of e-cigarettes and the development of prevention and intervention strategies.
Supplementary Material
Highlights.
Understanding how to assess e-cigarette dependence is important for public health
An expert group reviewed domains to consider when assessing e-cigarette dependence
External subject-matter experts provided feedback on potential dependence domains
10 final domains are reviewed as guidelines for assessing e-cigarette dependence
Acknowledgments
The authors would like to acknowledge the external expert review panel for providing valuable feedback and guidance related to e-cigarette dependence dimensions. This work was supported in part by grants from the National Institute on Drug Abuse and the FDA Center for Tobacco Products (CTP) (under Award Numbers P50DA036151 (SK-S, SSO); P50DA036107 (JF); T32DA019426 (KWB))
Role of funding sources: This work was supported in part by grants from the National Institute on Drug Abuse and the FDA Center for Tobacco Products (CTP) (under Award Numbers P50DA036151 (SK-S, SSO); P50DA036107 (JF); T32DA019426 (KWB)). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Food and Drug Administration.
J.F. has done paid consulting for pharmaceutical companies involved in producing smoking cessation medications including GSK, Pfizer, Novartis, J&J, and Cypress Bioscience, and has received a research grant and study drug from Pfizer. SSO reports the following activities related to alcohol research: Member of the American Society of Clinical Psychopharmacology workgroup, the Alcohol Clinical Trials Initiative, supported with funding from Amygdala, Eli Lilly, Ethypharma, Lundbeck, Pfizer, Otsuka, Arbor Pharmaceuticals, Indivior; donated study medications, Pfizer Pharmaceuticals, Astra Zeneca; DSMB member, Emmes Corporation; Consultant/Advisory Board Member, Opiant, Mitsubishi Tanabe, Alkermes, Amygdala.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Contributors: Authors SS, SSO, RG, JF, HF, SK-S were involved in the concept and design of the study as part of the TCORS Dependence Measurement Workgroup. Authors KWB, SS, SK-S wrote and revised the initial draft. All authors have read and approved the final manuscript.
Conflict of Interest: Other authors have no conflicts to declare.
References
- 1.USDHHS. A report of the Surgeon General. U.S. Department of Health and Human Services; Centers for Disease Control and Prevention; National Center for Chronic Disease Prevention and Health Promotion; Office on Smoking and Health; Atlanta, GA: 2016. E-cigarette use among youth and young adults. [Google Scholar]
- 2.Gravely S, Fong GT, Cummings KM, et al. Awareness, trial, and current use of electronic cigarettes in 10 countries: Findings from the ITC project. International journal of environmental research and public health. 2014;11(11):11691–11704. doi: 10.3390/ijerph111111691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.McMillen RC, Gottlieb MA, Shaefer RMW, Winickoff JP, Klein JD. Trends in electronic cigarette use among US adults: use is increasing in both smokers and nonsmokers. Nic Tob Res. 2015;17(10):1195–1202. doi: 10.1093/ntr/ntu213. [DOI] [PubMed] [Google Scholar]
- 4.Benowitz NL. Nicotine addiction. N Engl J Med. 2010;362(24):2295–2303. doi: 10.1056/NEJMra0809890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Sussman S. Substance and Behavioral Addictions: Concepts, Causes, and Cures. Cambridge University Press; 2017. [Google Scholar]
- 6.Sussman S, Sussman AN. Considering the definition of addiction. International Journal of Environmental Research and Public Health. 2011;8:4025–4038. doi: 10.3390/ijerph8104025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Rupprecht LE, Smith TT, Schassburger RL, Buffalari DM, Sved AF, Donny EC. The Neuropharmacology of Nicotine Dependence. Springer; 2015. Behavioral mechanisms underlying nicotine reinforcement. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Foulds J, Veldheer S, Yingst J, et al. Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking E-cigarette users. Nic Tob Res. 2015;17(2):186–192. doi: 10.1093/ntr/ntu204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Brown CJ, Cheng JM. Electronic cigarettes: product characterisation and design considerations. Tob Control. 2014;23(suppl 2):ii4–ii10. doi: 10.1136/tobaccocontrol-2013-051476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychological review. 2004;111(1):33. doi: 10.1037/0033-295X.111.1.33. [DOI] [PubMed] [Google Scholar]
- 11.Marsot A, Simon N. Nicotine and cotinine levels with electronic cigarette: a review. International journal of toxicology. 2016;35(2):179–185. doi: 10.1177/1091581815618935. [DOI] [PubMed] [Google Scholar]
- 12.Rostron BL, Schroeder MJ, Ambrose BK. Dependence symptoms and cessation intentions among US adult daily cigarette, cigar, and e-cigarette users, 2012–2013. BMC Public Health. 2016;16(1):814. doi: 10.1186/s12889-016-3510-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.American Psychological Association. Diagnostic and Statistical Manual of Mental Disorders. fifth. 2013. [Google Scholar]
- 14.Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends in cardiovascular medicine. 2016;26(6):515–523. doi: 10.1016/j.tcm.2016.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Grana RA, Benowitz N, Glantz SA. E-cigarettes: A scientific review. Circulation. 2014;129:1972–1986. doi: 10.1161/CIRCULATIONAHA.114.007667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bhatnagar A. E-cigarettes and cardiovascular disease risk: evaluation of evidence, policy implications, and recommendations. Current Cardiovascular Risk Reports. 2016;10(7):24. [Google Scholar]
- 17.DiFranza JR, Savageau JA, Fletcher K, et al. Symptoms of tobacco dependence after brief intermittent use: The development and assessment of nicotine dependence in youth–2 study. Arch Pediatr Adolesc Med. 2007;161(7):704–710. doi: 10.1001/archpedi.161.7.704. [DOI] [PubMed] [Google Scholar]
- 18.DiFranza JR, Savageau JA, Fletcher K, et al. Measuring the loss of autonomy over nicotine use in adolescents: the DANDY (Development and Assessment of Nicotine Dependence in Youths) study. Arch Pediatr Adolesc Med. 2002;156(4):397–403. doi: 10.1001/archpedi.156.4.397. [DOI] [PubMed] [Google Scholar]
- 19.Piper ME, Piasecki TM, Federman EB, et al. A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68) Journal of consulting and clinical psychology. 2004;72(2):139. doi: 10.1037/0022-006X.72.2.139. [DOI] [PubMed] [Google Scholar]
- 20.Tiffany ST. A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychological review. 1990;97(2):147. doi: 10.1037/0033-295x.97.2.147. [DOI] [PubMed] [Google Scholar]
- 21.Krishnan-Sarin S, Morean ME, Kong G, et al. "Dripping" among youth using e-cigarettes. Pediatrics. 2017;139(3):e20163224. doi: 10.1542/peds.2016-3224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Talih S, Balhas Z, Salman R, Karaoghlanian N, Shihadeh A. “Direct Dripping”: A High-Temperature, High-Formaldehyde Emission Electronic Cigarette Use Method. Nic Tob Res. 2015:ntv080. doi: 10.1093/ntr/ntv080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Pokhrel P, Herzog TA, Muranaka N, Fagan P. Young adult e-cigarette users’ reasons for liking and not liking e-cigarettes: a qualitative study. Psychology & health. 2015;30(12):1450–1469. doi: 10.1080/08870446.2015.1061129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kong G, Morean ME, Cavallo DA, Camenga DR, Krishnan-Sarin S. Reasons for electronic cigarette experimentation and discontinuation among adolescents and young adults. Nic Tob Res. 2015;17:847–854. doi: 10.1093/ntr/ntu257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Bickel WK, Johnson MW, Koffarnus MN, MacKillop J, Murphy JG. The behavioral economics of substance use disorders: reinforcement pathologies and their repair. Annual review of clinical psychology. 2014;10:641–677. doi: 10.1146/annurev-clinpsy-032813-153724. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Bickel WK, Mueller ET, Jarmolowicz DP. What is addiction? Addictions: A comprehensive guidebook. 2013;2:3–16. [Google Scholar]
- 27.Yingst JM, Veldheer S, Hammett E, Hrabovsky S, Foulds J. Should electronic cigarette use be covered by clean indoor air laws? Tob Control. 2017;26(e1):e16–e18. doi: 10.1136/tobaccocontrol-2016-053074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Zhu S-H, Sun JY, Bonnevie E, et al. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control. 2014;23(suppl 3):iii3–iii9. doi: 10.1136/tobaccocontrol-2014-051670. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Etter J-F. Throat hit in users of the electronic cigarette: An exploratory study. Psychology of Addictive Behaviors. 2016;30(1):93. doi: 10.1037/adb0000137. [DOI] [PubMed] [Google Scholar]
- 30.Shadel WG, Edelen MO, Tucker JS, Stucky BD, Hansen M, Cai L. Development of the PrOMis® nicotine Dependence item Banks. Nic Tob Res. 2014;16(Suppl 3):S190–S201. doi: 10.1093/ntr/ntu032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Edelen MO, Tucker JS, Shadel WG, Stucky BD, Cai L. Toward a more systematic assessment of smoking: Development of a smoking module for PROMIS®. Addict Behav. 2012;37(11):1278–1284. doi: 10.1016/j.addbeh.2012.06.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Edelen MO, Huang W, Stucky BD. Additional validity evidence for the PROMIS smoking assessment toolkit. Addict Behav. 2016;58:80–84. doi: 10.1016/j.addbeh.2016.02.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Baker TB, Breslau N, Covey L, Shiffman S. DSM criteria for tobacco use disorder and tobacco withdrawal: A critique and proposed revisions for DSM-5. Addiction. 2012;107(2):263–275. doi: 10.1111/j.1360-0443.2011.03657.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Etter J-F, Le Houezec J, Perneger TV. A self-administered questionnaire to measure dependence on cigarettes: the cigarette dependence scale. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2003;28(2):359. doi: 10.1038/sj.npp.1300030. [DOI] [PubMed] [Google Scholar]
- 35.Johnson JL, Ratner PA, Tucker RS, et al. Development of a multidimensional measure of tobacco dependence in adolescence. Addict Behav. 2005;30(3):501–515. doi: 10.1016/j.addbeh.2004.07.006. [DOI] [PubMed] [Google Scholar]
- 36.Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K. The Fagerström test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. British journal of addiction. 1991;86(9):1119–1127. doi: 10.1111/j.1360-0443.1991.tb01879.x. [DOI] [PubMed] [Google Scholar]
- 37.O’Loughlin J, DiFranza J, Tarasuk J, et al. Assessment of nicotine dependence symptoms in adolescents: a comparison of five indicators. Tob Control. 2002;11(4):354–360. doi: 10.1136/tc.11.4.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Hughes J, Hatsukami D. Errors in using tobacco withdrawal scale. Tob Control. 1998;7(1):92. doi: 10.1136/tc.7.1.92a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry. 1986;43(3):289–294. doi: 10.1001/archpsyc.1986.01800030107013. [DOI] [PubMed] [Google Scholar]
- 40.Shiffman S, Waters AJ, Hickcox M. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nic Tob Res. 2004;6(2):327–348. doi: 10.1080/1462220042000202481. [DOI] [PubMed] [Google Scholar]
- 41.National Institute of Health. National longitudinal study of tobacco use. 2017 https://pathstudyinfo.nih.gov/UI/StudyOverviewMobile.aspx.
- 42.Heishman SJ, Singleton EG, Moolchan ET. Tobacco Craving Questionnaire: reliability and validity of a new multifactorial instrument. Nic Tob Res. 2003;5(5):645–654. doi: 10.1080/1462220031000158681. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.